18 Biggest Mid-Day Losers For Thursday

Stemline Therapeutics Inc STML shares tumbled 32.8 percent to $6.55. A cancer patient died from side effect in Stemline Therapeutics’ SL-401 drug trial, according to TheStreet.com's Adam Feuerstein.
CSG Systems International, Inc. CSGS fell 17.6 percent to $39.76. CSG Systems reported a Q4 profit of $12.6 million on revenue of $195.2 million.
Seadrill Ltd SDRL dropped 17.6 percent to $1.62. Seadrill shares have gained 4.26 percent over the past 52 weeks, while the S&P 500 index has climbed 19.79 percent in the same period.
Resolute Forest Products Inc RFP shares dipped 15.6 percent to $4.60. Resolute reported a Q4 net loss of $45 million, or $0.50 per share, versus a year-ago net loss of $214 million , or $2.39 per share.
Shutterfly, Inc. SFLY shares declined 15.1 percent to $43.95 after the company reported weaker-than-expected Q4 results.
Corium International Inc CORI shares declined 14.5 percent to $3.15. Corium priced its follow-on offering of 6.66 million shares of common stock at $3 per share.
Aviragen Therapeutics Inc AVIR shares dropped 13.8 percent to $1.06 after the company reported top-line results from Phase 2a RSV challenge study of BTA585. The data depicted that there was not a significant reduction in primary endpoint.
Cirrus Logic, Inc. CRUS dropped 13.7 percent to $55.22. Cirrus Logic posted upbeat results for its third quarter.
Civeo Corporation (Canada) CVEO shares fell 12 percent to $3.17. Civeo reported an offering of 20 million shares of common stock.
Ralph Lauren Corp RL shares tumbled 11.7 percent to $77.13 after the company reported the departure of its CEO. Ralph Lauren reported Q3 adjusted earnings of $1.86 per share on revenue of $1.7 billion.
Edwards Lifesciences Corp EW dropped 9.4 percent to $88.79. Edwards Lifesciences reported Q4 adjusted earnings of $0.75 per share on revenue of $768 million. BTIG Research downgraded Edwards Lifesciences from Buy to Neutral.
Autoliv Inc. ALV shares fell 8.6 percent to $106.42 following weak Q4 results.
Mellanox Technologies, Ltd. MLNX declined 8.6 percent to $42.80 after reporting downbeat Q4 results.
First Bancorp FBP declined 7.8 percent to $6.32. First BanCorp disclosed that THL and Oaktree have commence secondary offering of shares.
Novo Nordisk A/S (ADR) NVO dropped 7.7 percent to $33.85 after reporting weak Q4 profit.
CymaBay Therapeutics Inc CBAY shares fell 6.3 percent to $1.95. CymaBay reported a proposed public offering of common stock.
CVS Health Corp CVS declined 4.6 percent to $74.39. Baird downgraded CVS Health from Outperform to Neutral.
Metlife Inc MET shares fell 3 percent to $52.25 after the company posted weaker-than-expected results for its fourth quarter.